Olive Garden waitress viral tip story exposed as fake
A heartwarming story about an Olive Garden waitress receiving a huge tip from a grieving customer turned out to be an elaborate fake that went viral across social media platforms.
A heartwarming story about an Olive Garden waitress receiving a huge tip from a grieving customer turned out to be an elaborate fake that went viral across social media platforms.
Exclusive investigation reveals sophisticated drone operations delivering contraband including diabetes medication Mounjaro used for weight loss and cosmetic products to prisoners across British jails.
Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.
Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.
A 57-year-old mother's dramatic weight loss success with diabetes drug Mounjaro led to emergency gallbladder surgery, raising questions about rapid transformation risks.
The NHS is poised to prescribe diabetes medication Mounjaro for weight loss in a groundbreaking move that could help millions of Britons struggling with obesity. Health Secretary Wes Streeting announces major expansion of weight management services.
Eli Lilly accuses the UK of having Europe's most challenging drug pricing system, threatening patient access to new medicines like Mounjaro amid ongoing NHS negotiations.
Pfizer announces a surprising turnaround in its weight-loss strategy, advancing two new daily pills in a heated battle for the lucrative obesity drug market dominated by injectables.
Exclusive guide reveals the tell-tale signs of fake Labubu dolls. Protect your investment and learn the crucial differences between authentic and counterfeit collectibles.
The NHS launches a new front in the fight against obesity, making the potent weight-loss drug Mounjaro available to thousands. Health Secretary Wes Streeting hails the move as a pivotal shift towards prevention.
Exclusive: Carly Stokes, a mother battling severe obesity, is denied access to the 'game-changer' drug Tirzepatide (Mounjaro) on the NHS despite its proven success, sparking outrage and a debate on healthcare funding.
The NHS in England launches a major new weapon against obesity, making the potent Mounjaro injection available to thousands through a specialist weight management service.
The NHS in England is set to rollout the powerful weight-loss injection Mounjaro (tirzepatide) through GP prescriptions, following a landmark NICE approval that could transform obesity treatment.
Former Gogglebox favourite Amy Tapper opens up exclusively about her life-changing 10-stone weight loss journey using diabetes drug Mounjaro, sharing her struggles and triumphs.
A landmark study presented in Vienna shows the diabetes drug tirzepatide (Mounjaro) leads to unprecedented weight loss in NHS patients, offering new hope in the fight against obesity.
A mother-of-four and competitive kickboxer has been exposed for faking a terminal cancer diagnosis to con her former partner out of thousands of pounds in a despicable fraud.
The NHS is rolling out a powerful new 4mg weekly injection of semaglutide, a 'game-changer' in weight loss treatment, as part of a major strategy to tackle the nation's obesity epidemic.
Former US President Donald Trump faces allegations of deploying artificial intelligence to create a fabricated image of himself with Black voters in a new social media campaign video, sparking widespread criticism and debates about digital ethics in polit
Jeremy Clarkson's chaotic National Television Awards speech saw him joke about his trousers falling down after a two-stone weight loss on Mounjaro, while forgetting to thank partner Lisa Hogan, creating a memorable and slightly awkward moment.
UK travellers using Ozempic, Wegovy, or Mounjaro face a critical insurance loophole. Experts reveal how these popular weight-loss and diabetes injections could leave you unprotected and facing massive medical bills abroad.
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Eli Lilly deals a major blow to UK Mounjaro users, announcing a smaller KwikPen, the removal of a key 12.5mg dose, and a staggering 170% price increase, sparking outrage and access fears.
Exclusive: Desperate UK diabetics face a devastating health crisis as they are cut off from the 'miracle' weight-loss drug Mounjaro (tirzepatide) due to soaring costs and an NHS postcode lottery, with patients fearing for their lives.
A British mother's life-changing journey from 30st to 8st using diabetes drug Mounjaro. Discover how this remarkable transformation saved her marriage and restored her health against all odds.
A groundbreaking new weight loss pill from Eli Lilly, orforglipron, has demonstrated remarkable results in a UK trial, offering a potential oral alternative to injectable treatments like Mounjaro for combating obesity.
A new oral weight loss medication, Orforglipron, shows transformative potential in UK clinical trials, matching the efficacy of injectable treatments like Mounjaro and offering new hope for tackling obesity.
Exclusive: The NHS is now prescribing powerful diabetes medications Ozempic and Mounjaro for weight loss, sparking a massive surge in demand and a fierce debate over ethics and supply.
An NHS administrator reveals how she lost four stone using a controversial cost-cutting method to obtain diabetes drug Mounjaro for weight loss, as doctors issue serious safety warnings.
The NHS in England is set to provide the highly effective Mounjaro (tirzepatide) weight-loss injection, hailed as a major breakthrough in fighting obesity and related diseases like type 2 diabetes.
Shocking new data reveals a stark postcode lottery for the diabetes and weight loss drug Mounjaro (tirzepatide) in England, with patients in some areas almost completely unable to access it on the NHS despite being eligible.